开始透析与持续医疗管理对肾衰竭老年人存活率和居家时间的影响:一项目标试验模拟研究。

IF 19.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Maria E Montez-Rath, I-Chun Thomas, Vivek Charu, Michelle C Odden, Carolyn D Seib, Shipra Arya, Enrica Fung, Ann M O'Hare, Susan P Y Wong, Manjula Kurella Tamura
{"title":"开始透析与持续医疗管理对肾衰竭老年人存活率和居家时间的影响:一项目标试验模拟研究。","authors":"Maria E Montez-Rath, I-Chun Thomas, Vivek Charu, Michelle C Odden, Carolyn D Seib, Shipra Arya, Enrica Fung, Ann M O'Hare, Susan P Y Wong, Manjula Kurella Tamura","doi":"10.7326/M23-3028","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>For older adults with kidney failure who are not referred for transplant, medical management is an alternative to dialysis.</p><p><strong>Objective: </strong>To compare survival and home time between older adults who started dialysis at an estimated glomerular filtration rate (eGFR) less than 12 mL/min/1.73 m<sup>2</sup> and those who continued medical management.</p><p><strong>Design: </strong>Observational cohort study using target trial emulation.</p><p><strong>Setting: </strong>U.S. Department of Veterans Affairs, 2010 to 2018.</p><p><strong>Participants: </strong>Adults aged 65 years or older with chronic kidney failure and eGFR below 12 mL/min/1.73 m<sup>2</sup> who were not referred for transplant.</p><p><strong>Intervention: </strong>Starting dialysis within 30 days versus continuing medical management.</p><p><strong>Measurements: </strong>Mean survival and number of days at home.</p><p><strong>Results: </strong>Among 20 440 adults (mean age, 77.9 years [SD, 8.8]), the median time to dialysis start was 8.0 days in the group starting dialysis and 3.0 years in the group continuing medical management. Over a 3-year horizon, the group starting dialysis survived 770 days and the group continuing medical management survived 761 days (difference, 9.3 days [95% CI, -17.4 to 30.1 days]). Compared with the group continuing medical management, the group starting dialysis had 13.6 fewer days at home (CI, 7.7 to 20.5 fewer days at home). Compared with the group continuing medical management and forgoing dialysis completely, the group starting dialysis had longer survival by 77.6 days (CI, 62.8 to 91.1 days) and 14.7 fewer days at home (CI, 11.2 to 16.5 fewer days at home).</p><p><strong>Limitation: </strong>Potential for unmeasured confounding due to lack of symptom assessments at eligibility; limited generalizability to women and nonveterans.</p><p><strong>Conclusion: </strong>Older adults starting dialysis when their eGFR fell below 12 mL/min/1.73 m<sup>2</sup> who were not referred for transplant had modest gains in life expectancy and less time at home.</p><p><strong>Primary funding source: </strong>U.S. Department of Veterans Affairs and National Institutes of Health.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure : A Target Trial Emulation Study.\",\"authors\":\"Maria E Montez-Rath, I-Chun Thomas, Vivek Charu, Michelle C Odden, Carolyn D Seib, Shipra Arya, Enrica Fung, Ann M O'Hare, Susan P Y Wong, Manjula Kurella Tamura\",\"doi\":\"10.7326/M23-3028\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>For older adults with kidney failure who are not referred for transplant, medical management is an alternative to dialysis.</p><p><strong>Objective: </strong>To compare survival and home time between older adults who started dialysis at an estimated glomerular filtration rate (eGFR) less than 12 mL/min/1.73 m<sup>2</sup> and those who continued medical management.</p><p><strong>Design: </strong>Observational cohort study using target trial emulation.</p><p><strong>Setting: </strong>U.S. Department of Veterans Affairs, 2010 to 2018.</p><p><strong>Participants: </strong>Adults aged 65 years or older with chronic kidney failure and eGFR below 12 mL/min/1.73 m<sup>2</sup> who were not referred for transplant.</p><p><strong>Intervention: </strong>Starting dialysis within 30 days versus continuing medical management.</p><p><strong>Measurements: </strong>Mean survival and number of days at home.</p><p><strong>Results: </strong>Among 20 440 adults (mean age, 77.9 years [SD, 8.8]), the median time to dialysis start was 8.0 days in the group starting dialysis and 3.0 years in the group continuing medical management. Over a 3-year horizon, the group starting dialysis survived 770 days and the group continuing medical management survived 761 days (difference, 9.3 days [95% CI, -17.4 to 30.1 days]). Compared with the group continuing medical management, the group starting dialysis had 13.6 fewer days at home (CI, 7.7 to 20.5 fewer days at home). Compared with the group continuing medical management and forgoing dialysis completely, the group starting dialysis had longer survival by 77.6 days (CI, 62.8 to 91.1 days) and 14.7 fewer days at home (CI, 11.2 to 16.5 fewer days at home).</p><p><strong>Limitation: </strong>Potential for unmeasured confounding due to lack of symptom assessments at eligibility; limited generalizability to women and nonveterans.</p><p><strong>Conclusion: </strong>Older adults starting dialysis when their eGFR fell below 12 mL/min/1.73 m<sup>2</sup> who were not referred for transplant had modest gains in life expectancy and less time at home.</p><p><strong>Primary funding source: </strong>U.S. Department of Veterans Affairs and National Institutes of Health.</p>\",\"PeriodicalId\":7932,\"journal\":{\"name\":\"Annals of Internal Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":19.6000,\"publicationDate\":\"2024-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Internal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7326/M23-3028\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7326/M23-3028","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:对于未接受移植手术的肾衰竭老年人来说,药物治疗是透析的一种替代方法:比较估计肾小球滤过率(eGFR)低于 12 mL/min/1.73 m2 时开始透析的老年人与继续接受药物治疗的老年人的存活率和居家时间:观察性队列研究,采用目标试验模拟法:美国退伍军人事务部,2010 年至 2018 年:年龄在 65 岁或以上、患有慢性肾衰竭且 eGFR 低于 12 mL/min/1.73 m2 且未转诊接受移植手术的成年人:干预措施:30 天内开始透析与持续医疗管理:测量:平均存活率和在家透析天数:结果:在 20 440 名成人(平均年龄 77.9 岁 [SD, 8.8])中,开始透析组的中位透析时间为 8.0 天,而继续医疗管理组的中位透析时间为 3.0 年。在 3 年的时间里,开始透析组存活了 770 天,继续接受药物治疗组存活了 761 天(差异为 9.3 天 [95% CI,-17.4 至 30.1 天])。与持续医疗管理组相比,开始透析组的居家天数减少了 13.6 天(CI,减少 7.7 至 20.5 天)。与继续接受药物治疗和完全放弃透析的组别相比,开始透析的组别生存期延长了77.6天(CI,62.8至91.1天),在家的天数减少了14.7天(CI,11.2至16.5天):局限性:由于缺乏合格时的症状评估,可能存在未测量的混杂因素;对女性和非退伍军人的普遍性有限:结论:当 eGFR 低于 12 mL/min/1.73 m2 时开始透析但未被转诊进行移植的老年人的预期寿命略有延长,在家的时间也有所减少:主要资金来源:美国退伍军人事务部和美国国立卫生研究院。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure : A Target Trial Emulation Study.

Background: For older adults with kidney failure who are not referred for transplant, medical management is an alternative to dialysis.

Objective: To compare survival and home time between older adults who started dialysis at an estimated glomerular filtration rate (eGFR) less than 12 mL/min/1.73 m2 and those who continued medical management.

Design: Observational cohort study using target trial emulation.

Setting: U.S. Department of Veterans Affairs, 2010 to 2018.

Participants: Adults aged 65 years or older with chronic kidney failure and eGFR below 12 mL/min/1.73 m2 who were not referred for transplant.

Intervention: Starting dialysis within 30 days versus continuing medical management.

Measurements: Mean survival and number of days at home.

Results: Among 20 440 adults (mean age, 77.9 years [SD, 8.8]), the median time to dialysis start was 8.0 days in the group starting dialysis and 3.0 years in the group continuing medical management. Over a 3-year horizon, the group starting dialysis survived 770 days and the group continuing medical management survived 761 days (difference, 9.3 days [95% CI, -17.4 to 30.1 days]). Compared with the group continuing medical management, the group starting dialysis had 13.6 fewer days at home (CI, 7.7 to 20.5 fewer days at home). Compared with the group continuing medical management and forgoing dialysis completely, the group starting dialysis had longer survival by 77.6 days (CI, 62.8 to 91.1 days) and 14.7 fewer days at home (CI, 11.2 to 16.5 fewer days at home).

Limitation: Potential for unmeasured confounding due to lack of symptom assessments at eligibility; limited generalizability to women and nonveterans.

Conclusion: Older adults starting dialysis when their eGFR fell below 12 mL/min/1.73 m2 who were not referred for transplant had modest gains in life expectancy and less time at home.

Primary funding source: U.S. Department of Veterans Affairs and National Institutes of Health.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annals of Internal Medicine
Annals of Internal Medicine 医学-医学:内科
CiteScore
23.90
自引率
1.80%
发文量
1136
审稿时长
3-8 weeks
期刊介绍: Established in 1927 by the American College of Physicians (ACP), Annals of Internal Medicine is the premier internal medicine journal. Annals of Internal Medicine’s mission is to promote excellence in medicine, enable physicians and other health care professionals to be well informed members of the medical community and society, advance standards in the conduct and reporting of medical research, and contribute to improving the health of people worldwide. To achieve this mission, the journal publishes a wide variety of original research, review articles, practice guidelines, and commentary relevant to clinical practice, health care delivery, public health, health care policy, medical education, ethics, and research methodology. In addition, the journal publishes personal narratives that convey the feeling and the art of medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信